ArticleInternal medicine (Tokyo, Japan)2020

Efficacy and Safety of Modified FOLFOXIRI+α in the Treatment of Advanced and Recurrent Colorectal Cancer: A Single-center Experience.

Kazuma Kobayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.